Clinical trial NCT06312072 - References

Chronic Kidney Diseases — Understanding Risk Factors for Progressive Chronic Kidney Disease in Malawi

Citation(s)

•   Agrawal V, Marinescu V, Agarwal M, McCullough PA
  Cardiovascular implications of proteinuria: an indicator of chronic kidney disease. Nat Rev Cardiol. 2009 Apr;6(4):301-11. doi: 10.1038/nrcardio.2009.11.
•   Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators
  Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23.
•   Commission NP
  The Malawi Noncommunicable Diseases & Injuries Poverty Commission Report. Lilongwe: Malawi Ministry of Health, 2018. http://www.ncdipoverty.org/malawi-report
•   Crampin AC, Dube A, Mboma S, Price A, Chihana M, Jahn A, Baschieri A, Molesworth A, Mwaiyeghele E, Branson K, Floyd S, McGrath N, Fine PE, French N, Glynn JR, Zaba B
  Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol. 2012 Jun;41(3):676-85. doi: 10.1093/ije/dys088. Epub 2012 Jun 22.
•   Dreyer G, Dobbie H, Banks R, Allain T, Gonani A, Turner NLV
  Supporting Malawi's dialysis services in the international community. Br J Ren Med. 2012;17:24-6.
•   Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Kottgen A, Levey AS, Levin A
  Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013 Jul 13;382(9887):158-69. doi: 10.1016/S0140-6736(13)60439-0. Epub 2013 May 31.
•   Fabian J, George JA, Etheredge HR, van Deventer M, Kalyesubula R, Wade AN, Tomlinson LA, Tollman S, Naicker S
  Methods and reporting of kidney function: a systematic review of studies from sub-Saharan Africa. Clin Kidney J. 2019 Aug 19;12(6):778-787. doi: 10.1093/ckj/sfz089. eCollection 2019 Dec.
•   Fabian J, Kalyesubula R, Mkandawire J, Hansen CH, Nitsch D, Musenge E, Nakanga WP, Prynn JE, Dreyer G, Snyman T, Ssebunnya B, Ramsay M, Smeeth L, Tollman S, Naicker S, Crampin A, Newton R, George JA, Tomlinson L; African Research on Kidney Disease Consortium
  Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study. Lancet Glob Health. 2022 Aug;10(8):e1159-e1169. doi: 10.1016/S2214-109X(22)00239-X.
•   GBD Chronic Kidney Disease Collaboration
  Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
•   Heerspink HJL, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjostrom CD, Toto RD, Langkilde AM, Wheeler DC; DAPA-CKD Trial Committees and Investigators
  Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020 Oct 8;383(15):1436-1446. doi: 10.1056/NEJMoa2024816. Epub 2020 Sep 24.
•   https://www
  theisn.org/blog/2014/11/24/caring-for-kidney-patients-in-malawi/
•   Kalyesubula R, Nankabirwa JI, Ssinabulya I, Siddharthan T, Kayima J, Nakibuuka J, Salata RA, Mondo C, Kamya MR, Hricik D
  Kidney disease in Uganda: a community based study. BMC Nephrol. 2017 Apr 3;18(1):116. doi: 10.1186/s12882-017-0521-x.
•   Kaze AD, Ilori T, Jaar BG, Echouffo-Tcheugui JB
  Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis. BMC Nephrol. 2018 Jun 1;19(1):125. doi: 10.1186/s12882-018-0930-5.
•   Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, Fox CS, Gansevoort RT, Heerspink HJL, Jardine M, Kasiske B, Kottgen A, Kretzler M, Levey AS, Luyckx VA, Mehta R, Moe O, Obrador G, Pannu N, Parikh CR, Perkovic V, Pollock C, Stenvinkel P, Tuttle KR, Wheeler DC, Eckardt KU; ISN Global Kidney Health Summit participants
  Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017 Oct 21;390(10105):1888-1917. doi: 10.1016/S0140-6736(17)30788-2. Epub 2017 Apr 20.
•   Luyckx VA, Moosa MR
  Priority Setting as an Ethical Imperative in Managing Global Dialysis Access and Improving Kidney Care. Semin Nephrol. 2021 May;41(3):230-241. doi: 10.1016/j.semnephrol.2021.05.004.
•   Muiru AN, Charlebois ED, Balzer LB, Kwarisiima D, Elly A, Black D, Okiror S, Kabami J, Atukunda M, Snyman K, Petersen M, Kamya M, Havlir D, Estrella MM, Hsu CY
  The epidemiology of chronic kidney disease (CKD) in rural East Africa: A population-based study. PLoS One. 2020 Mar 4;15(3):e0229649. doi: 10.1371/journal.pone.0229649. eCollection 2020.
•   Nakanga WP, Prynn JE, Banda L, Kalyesubula R, Tomlinson LA, Nyirenda M, Crampin AC
  Prevalence of impaired renal function among rural and urban populations: findings of a cross-sectional study in Malawi. Wellcome Open Res. 2019 Jun 10;4:92. doi: 10.12688/wellcomeopenres.15255.1. eCollection 2019.
•   Okpechi IG, Bello AK, Ameh OI, Swanepoel CR
  Integration of Care in Management of CKD in Resource-Limited Settings. Semin Nephrol. 2017 May;37(3):260-272. doi: 10.1016/j.semnephrol.2017.02.006.
•   Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL
  Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med. 1995 Nov 15;123(10):754-62. doi: 10.7326/0003-4819-123-10-199511150-00003.
•   Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
  The EUCLID Study Group. Lancet. 1997 Jun 21;349(9068):1787-92.
•   Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, Remuzzi G
  Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int Suppl. 1997 Dec;63:S54-7.
•   Ruggenenti P, Perna A, Remuzzi G
  ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J Am Soc Nephrol. 2001 Dec;12(12):2832-2837. doi: 10.1681/ASN.V12122832.
•   Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, Patel U
  The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014 Mar;2(3):e174-81. doi: 10.1016/S2214-109X(14)70002-6. Epub 2014 Feb 10. Erratum In: Lancet Glob Health. 2014 May;2(5):266.
•   Stanifer JW, Maro V, Egger J, Karia F, Thielman N, Turner EL, Shimbi D, Kilaweh H, Matemu O, Patel UD
  The epidemiology of chronic kidney disease in Northern Tanzania: a population-based survey. PLoS One. 2015 Apr 17;10(4):e0124506. doi: 10.1371/journal.pone.0124506. eCollection 2015.
•   The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R
  Empagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4.
•   World Health Organization
  Strengthening Health Systems to Improve Health Outcomes. https://www.who.int/healthsystems/ strategy/en/. 2007. Accessed February 26, 2021

Understanding Risk Factors for Progressive Chronic Kidney Disease in Malawi to Inform Interventions for Earlier Detection and Prevention (Impso Study)

Details for clinical trial NCT06312072